$FPH

Five Point Holdings, LLC

1
0
0

No SEC Form 4 filings for $FPH in the last 30 days.

See all $FPH insider activity →
Med

NZX 50 falls as investors want more from Chorus; Infratil dips

New Zealand's S&P/NZX 50 index fell 0.7% as Chorus declined 5.3% after its earnings outlook missed expectations, while Fisher & Paykel Healthcare rose 1.6% following upgraded price targets. Infratil dropped 2.1%, and SkyCity Entertainment Group surged 9.9% on potential takeover interest. Asian markets also declined, led by Alibaba's 9.8% drop.

Market quiet but earnings showing positive signs

Fisher & Paykel Healthcare upgraded its 2027 guidance, citing strong hospital product sales. Revenue and net profit forecasts increased, with first-half revenue expected at $1.24B and net profit at $280M. The stock closed at $43.52. On Wall Street, the Dow fell 1.32% as bond yields rose and Walmart missed earnings. In NZ, several companies reported earnings, including South Port NZ and Seeka.

FPH provides first half FY27 guidance, updates FY27 outlook

Fisher & Paykel Healthcare (FPH) provided first-half FY27 guidance, expecting $1.24B revenue and $280M net profit, up 14% and 24% respectively. Full-year outlook raised to $2.47B-$2.57B revenue and $525M-$565M net profit, including $23M in tariff refunds. Growth driven by strong demand and clinical practice changes.

FPH sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning FPH (Five Point Holdings, LLC). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent FPH coverage spans earnings, corporate actions and mergers & acquisitions.

What's driving FPH

alphai scores every news story that mentions FPH with an AI model for sentiment and relevance, and aggregates insider trades from Five Point Holdings, LLC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $FPH

Score
$FPHMed

NZX 50 falls as investors want more from Chorus; Infratil dips

New Zealand's S&P/NZX 50 index fell 0.7% as Chorus declined 5.3% after its earnings outlook missed expectations, while Fisher & Paykel Healthcare rose 1.6% following upgraded price targets. Infratil dropped 2.1%, and SkyCity Entertainment Group surged 9.9% on potential takeover interest. Asian markets also declined, led by Alibaba's 9.8% drop.

$FPHMedAI 8/10

Market quiet but earnings showing positive signs

Fisher & Paykel Healthcare upgraded its 2027 guidance, citing strong hospital product sales. Revenue and net profit forecasts increased, with first-half revenue expected at $1.24B and net profit at $280M. The stock closed at $43.52. On Wall Street, the Dow fell 1.32% as bond yields rose and Walmart missed earnings. In NZ, several companies reported earnings, including South Port NZ and Seeka.

First Phil Holdings rejects KKR bid for First Gen stake

First Philippine Holdings (FPH) said it rejected KKR’s non-binding bid to buy FPH’s 8.43% stake in First Gen and launch a voluntary tender offer for First Gen’s 11.67% public float at P35 per share. FPH said the proposal does not reflect First Gen’s true value and ended its participation. FPH shares fell P1 to P102; First Gen fell P3.50 to P27.20.

$KKRMed

Making sense of US firm KKR’s offer on Lopez family’s First Gen

KKR emailed First Philippine Holdings (FPH) and First Gen Corp. on July 10 with a three-step plan, disclosed in an Aug. 13 letter to the PSE. KKR would buy 8.43% of First Gen from FPH, then buy the 11.67% public float, and seek delisting. KKR says any change-of-control deal would trigger a mandatory tender offer and a control premium at least 30% above its offer price (about P46 vs ~P35).

$CRWVMed

NZX 50 slides for 2nd day as Oz’s mortgage chill crosses Tasman

The NZX 50 fell for a second day, down 0.9% to 13,737.66, with oil prices rising and mortgage application weakness in Australia weighing on sentiment. Mainfreight, Auckland Airport and Fletcher Building declined. Scott Technology rose after forecasting record FY results. Australia’s CBA fell 0.7% to A$172.73; Westpac and ANZ also dropped.

Ramon Ang acquires 25.68% stake in Lopez Inc. from Gabby Lopez family branch — Dateline Philippines

Ramon S. Ang, via Ilumina Investment Holdings he wholly owns, bought a 25.68% stake in Lopez Inc. from Crème Investment Corp., representing the Lopez III family branch, according to corporate disclosures. The price was not disclosed. Ang’s minority stake does not change control, which remains with other Lopez branches. San Miguel said the investment was personal, not an acquisition.

$FPHMed

Lopez family confirms a sale inside ultimate parent firm Lopez Inc.

First Philippine Holdings (FPH) said director Roberta Lopez-Feliciano resigned effective Aug. 9, citing that Crème Investment Corporation sold its shares in Lopez Inc., the private parent above FPH. The filing was made under SEC Form 17-C Item 4 (director/officer change), not change in control. Crème held 25.68% of Lopez Inc.

Related tickers